Beijing Winsunny Pharmaceutical CO.LTD (SHG:601089) — Market Cap & Net Worth
Market Cap & Net Worth: Beijing Winsunny Pharmaceutical CO.LTD (601089)
Beijing Winsunny Pharmaceutical CO.LTD (SHG:601089) has a market capitalization of $1.18 Billion (CN¥8.05 Billion) as of June 23, 2026. Listed on the SHG stock exchange, this China-based company holds position #8347 globally and #2040 in its home market, demonstrating a 1.15% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Beijing Winsunny Pharmaceutical CO.LTD's stock price CN¥16.77 by its total outstanding shares 480000000 (480.00 Million). Review total liabilities of Beijing Winsunny Pharmaceutical CO.LTD to assess the company's total debt and financial obligations.
Beijing Winsunny Pharmaceutical CO.LTD Market Cap History: 2022 to 2026
Beijing Winsunny Pharmaceutical CO.LTD's market capitalization history from 2022 to 2026. Data shows change from $1.02 Billion to $1.18 Billion (-4.22% CAGR).
Beijing Winsunny Pharmaceutical CO.LTD Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Beijing Winsunny Pharmaceutical CO.LTD's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.33x
Beijing Winsunny Pharmaceutical CO.LTD's market cap is 0.33 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.30x
Beijing Winsunny Pharmaceutical CO.LTD's market cap is 2.30 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $1.02 Billion | $3.24 Billion | $438.90 Million | 0.31x | 2.32x |
| 2023 | $1.17 Billion | $3.34 Billion | $488.77 Million | 0.35x | 2.39x |
| 2024 | $1.12 Billion | $3.45 Billion | $488.67 Million | 0.33x | 2.30x |
Competitor Companies of 601089 by Market Capitalization
Companies near Beijing Winsunny Pharmaceutical CO.LTD in the global market cap rankings as of June 23, 2026.
Key companies related to Beijing Winsunny Pharmaceutical CO.LTD by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #554 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #602 globally with a market cap of $45.20 Billion USD ( CN¥308.87 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #627 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #515 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #554 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.94 |
| #602 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.20 Billion | CN¥48.42 |
| #627 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.50 |
Beijing Winsunny Pharmaceutical CO.LTD Historical Marketcap From 2022 to 2026
Between 2022 and today, Beijing Winsunny Pharmaceutical CO.LTD's market cap moved from $1.02 Billion to $ 1.18 Billion, with a yearly change of -4.22%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.18 Billion | -30.12% |
| 2025 | CN¥1.69 Billion | +50.00% |
| 2024 | CN¥1.12 Billion | -3.92% |
| 2023 | CN¥1.17 Billion | +14.91% |
| 2022 | CN¥1.02 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 22nd, 2026 the market cap of Beijing Winsunny Pharmaceutical CO.LTD was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.18 Billion USD |
| MoneyControl | $1.18 Billion USD |
| MarketWatch | $1.18 Billion USD |
| marketcap.company | $1.18 Billion USD |
| Reuters | $1.18 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Beijing Winsunny Pharmaceutical CO.LTD
Beijing Foyou Pharma CO.,LTD engages in the research and development, production, and sale of pharmaceutical preparations and medical devices China and internationally. The company provides chemical drugs and traditional chinese medicines. Its products used in cardiovascular kind, chronic kidney disease, skin disease, digestive system, diabetes, neuropsychiatric system kind, mental nervous system… Read more